Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Public ClinicalTrials.gov record NCT01467882. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Non-comparative, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Triptorelin Pamoate (Embonate) 22.5 mg 6-month Formulation in Patients Suffering From Central (Gonadotropin-dependent) Precocious Puberty
Study identification
- NCT ID
- NCT01467882
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Debiopharm International SA
- Industry
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Interventions
- Triptorelin Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 9 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2012
- Primary completion
- Jul 31, 2013
- Completion
- Jun 30, 2014
- Last update posted
- Jul 27, 2017
2012 – 2014
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pediatric Endocrinology of Phoenix | Phoenix | Arizona | 85053 | — |
| Children's National Medical Center | San Diego | California | — | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | — | — |
| Arnold Palmer Pediatric Endocrinology Practice | Orlando | Florida | — | — |
| Nancy Wright MD P.A. | Tallahassee | Florida | 32308 | — |
| Washington University | St Louis | Missouri | — | — |
| Hackensack university medical center | Hackensack | New Jersey | — | — |
| Women's & Children's Hospital of Buffalo | Buffalo | New York | — | — |
| Cincinnati Children's Hospital | Cincinnati | Ohio | — | — |
| Lynn health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Swedish Pediatric Specialist | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01467882, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2017 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01467882 live on ClinicalTrials.gov.